1.C. Yu, S. Ding, Therapeutic strategies targeting somatic stem cells: Chemical approaches.Bioorganic & Medicinal Chemistry.28, 115824 (2020).

2. Y. Liu*,C. Yu*, T. P. Daley*, F. Wang, W. S. Cao, S. Bhate, X. Lin, C. Still, H. Liu, D. Zhao, H. Wang, X. S. Xie, S. Ding, W. H. Wong, M. Wernig, L. S. Qi, CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming.Cell Stem Cell.23, 758-771.e8 (2018).(*co-first author)

3. K. Liu*,C. Yu*, M. Xie*, K. Li, S. Ding, Chemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine.Cell Chemical Biology.23, 893–916 (2016). (*co-first author)

4.C. Yu, Y. Liu, T. Ma, K. Liu, S. Xu, Y. Zhang, H. Liu, M. La Russa, M. Xie, S. Ding, L. S. Qi, Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells.Cell Stem Cell.16, 142–147 (2015).

5. Y. Zhang, N. Cao, Y. Huang, C. I. Spencer, J. Fu,C. Yu, K. Liu, B. Nie, T. Xu, K. Li, S. Xu, B. G. Bruneau, D. Srivastava, S. Ding, Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts.Cell Stem Cell.18, 368–381 (2016).